注册并分享邀请链接,可获得视频播放与邀请奖励。

Antonio Linares
@alc2022
100x investor, bio/acc. do your own research. Early $AMD, $TSLA, $PLTR, $SPOT, $HIMS, $DUOL, $IBRX, $NAUT.
加入 November 2020
410 正在关注    163.7K 粉丝
Peptides are a write function. Biology is code. The winner won’t be whoever makes the molecule. It’ll be whoever owns the patient data and the AI that matches each person to the optimal write function. That’s $HIMS.
显示更多
everyone gave up on $HIMS in february 2026 the stock is up ~3X since $hims is a not a GLP-1 company, but a Healthcare Ontology $2,000/share intrinsic value by the year 2030
0
4
243
14
转发到社区